Skip to main content
. Author manuscript; available in PMC: 2014 Dec 23.
Published in final edited form as: Mol Ther Methods Clin Dev. 2014;1:14033. doi: 10.1038/mtm.2014.33

Table 1.

Safety data

Day-30 Day -1 Day 1 Day 3 Day 14 Day 90 Day 180 Day 270
IgG (mg/dL) 674 - - - - 994 - 1209
IgA (mg/dL) <5 - - - - <5 - <5
WBC (thou/cu mm) 15.3 8.4 5.5 10.5 7.5 12.3 5.6 8.1
Platelet (thou/cu mm) 481 403 385 491 389 374 304 324
Neutrophil (%) 61 16.6 24 23.8 29 69.7 29 48.1
Lymphocyte (%) 12 58.5 63 60.5 49.2 19 50.9 39.8
Monocyte (%) 5 6.6 9 10.2 8 7.7 13 7
Eosinophil (%) 1 16.2 3 3 10.1 2.3 4.2 2.4
Basophil (%) 0 0.4 0 0.6 0.7 0.2 0.5 0.4
RBC (mill/cu mm) 4.42 4.61 4.33 4.75 4.54 5.17 5.12 5.2
AST 366 484 445 438 469 496 575 436
ALT 246 306 287 316 239 277 426 292
CD20% 0 - - - - 0 - 4
CD3% 80 - - - - 86 - 88
NT-PRO-BNP 225 - - - - 44 - -
CK (U/L) 2549 1967 1518 1170 2433 2858 2613 -
CKMB (ng/mL) 22.7 - - - - 22.8 - -